Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-miRNA therapeutics for uterine fibroids

28 Feb 2025

Abstract excerpt

BACKGROUND: Uterine leiomyomas arise from altered uterine smooth muscle cell proliferation in the myometrium. Available treatments are limited and fraught with major side effects. Here, we leveraged data from a high-throughput screening using human microRNA mimics and selected miR-148a-3p as a therapeutic target. The study aimed to assess the therapeutic potential of a miR-148a-3p inhibitor in suppressing the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometriosis Research and Treatment
Share to Gynecological conditions and treatments
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40022993
DOI: 10.1016/j.biopha.2025.117946

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-miRNA therapeutics for uterine fibroidsPMID 40022993Read ↗

MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Semantic proximity Read ↗

The Role of MicroRNAs in Uterine Leiomyosarcoma Diagnosis and TreatmentSemantic proximity Read ↗

Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approachSemantic proximity Read ↗

Oncomirs Expression Profiling in Uterine Leiomyosarcoma CellsSemantic proximity Read ↗

Characterization of the uterine leiomyoma microRNAome by deep sequencingSemantic proximity Read ↗

Integrative transcriptomics analysis for uterine leiomyosarcoma identifies aberrant activation of cell cycle-dependent kinases and their potential therapeutic significanceSemantic proximity Read ↗

Expression Profiling of IncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA SequencingSemantic proximity Read ↗

The Future of Targeted Therapy for LeiomyosarcomaSemantic proximity Read ↗

Recent Advances in Uterine Fibroid Etiology.Semantic proximity Read ↗

Expression Profiling of Nuclear Receptors Identifies Key Roles of NR4A Subfamily in Uterine FibroidsSemantic proximity Read ↗

Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Semantic proximity Read ↗

A micro‐RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.